David A. Siegel Assertio Holdings, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,129,534 shares of ASRT stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,129,534

Previous 1,220,415 7.45%

Holding current value

$1.54 Million

Previous $1.31 Million 16.93%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.79 - $1.14 $71,795 - $103,604	-90,881 Reduced 7.45%	1,129,534 $1.08 Million
Q4 2023 Feb 14, 2024	BUY	$1.02 - $2.57 $740,806 - $1.87 Million	726,281 Added 146.98%	1,220,415 $1.31 Million
Q3 2023 Nov 14, 2023	BUY	$2.52 - $5.69 $720,468 - $1.63 Million	285,900 Added 137.3%	494,134 $1.26 Million
Q2 2023 Aug 14, 2023	BUY	$5.0 - $7.66 $116,625 - $178,669	23,325 Added 12.61%	208,234 $1.13 Million
Q1 2023 May 15, 2023	SELL	$3.54 - $6.66 $427,012 - $803,362	-120,625 Reduced 39.48%	184,909 $1.18 Million

Q4 2022 Feb 14, 2023	BUY	$2.48 - $4.3 $546,544 - $947,638	220,381 Added 258.81%	305,534 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $35,044 - $65,812	16,453 Added 23.95%	85,153 $193,000
Q2 2022 Aug 15, 2022	BUY	$1.88 - $3.42 $14,476 - $26,334	7,700 Added 12.62%	68,700 $203,000
Q1 2022 May 16, 2022	SELL	$2.06 - $3.0 $11,536 - $16,800	-5,600 Reduced 8.41%	61,000 $175,000
Q4 2021 Feb 14, 2022	BUY	$0.86 - $2.3 $43,258 - $115,689	50,300 Added 308.59%	66,600 $145,000
Q3 2021 Nov 15, 2021	BUY	$0.89 - $1.55 $14,507 - $25,265	16,300 New	16,300 $15,000

Others Institutions Holding ASRT

# of Institutions

116

Shares Held

44.7M

Call Options Held

571K

Put Options Held

275K

View Full List

About Assertio Holdings, Inc.

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $65.5M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

More about ASRT

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account